‘Prolempaino’ Obesity Program Ends Abruptly: 46,000 Patients Left Without Free Medication
Greece’s Prolempaino obesity program ended 30 June 2026, leaving 46,000 patients without free medication and care. Efforts underway to restart in September. The post ‘Prolempaino’ Obesity Program…
Read the full articleYou might also wanna read
Greece Obesity Treatment Program Faces Funding Uncertainty
Around 46,000 participants in Greece’s free obesity treatment programme face a possible interruption as authorities seek emergency funding t
What Happens When You Stop Taking GLP-1 Weight Loss Medications
You may have lost the weight you wanted to lose - but now you've stopped the jabs, how easy is it to keep it off?
bbc.com·6mo ago
New GLP-1 Drug Promotes Weight Loss in Obesity
A new strategy for delivering GLP-1 drugs to patients with obesity or who were overweight resulted in up to an 11 percent reduction in body
Study: Most Patients Regain Weight and Lose Health Benefits After Stopping GLP-1 Drugs
In trial, 82% saw weight rebound and cardiovascular health reverse after withdrawal.
arstechnica.com·7mo ago
Medicare begins covering weight-loss medications: who qualifies and how the new program will work
A pilot program will, for the first time, allow millions of beneficiaries to access GLP-1 medications to treat obesity with a monthly copay
Pilot program to provide cheaper GLP-1 via Medicare stokes shortage fears
Some adults aged 65 and above will be able to get the drug for $50 through Medicare GLP-1, a temporary program Kathryn, a retiree who worked
Comments
Sign in to join the conversation.
No comments yet. Be the first.